small molecule against a non-canonical pathway enzyme (Invivoscribe Technologies/Domainex)

N/A

Report date: 2025/01/26 15:32:16
NME

Base Information

Drug Namesmall molecule against a non-canonical pathway enzyme (Invivoscribe Technologies/Domainex)
Drug Alias Namesmall molecule program (Invivoscribe)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsLeukemia, Myeloid, Acute
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesInvivoscribe Technologies Inc
China Registration ClassN/A

Develop Information

Active CompaniesInvivoscribe Technologies Inc
Inactive CompaniesN/A
Active IndicationsLeukemia, Myeloid, Acute
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A